Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.
Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.
复制标题
DOI:
10.3390/biomedicines5030050
复制
发表时间:
2017-08-22
期刊:
影响因子:
4.7
通讯作者:
Franzoso G
中科院分区:
文献类型:
--
作者:
Begalli F;Bennett J;Capece D;Verzella D;D'Andrea D;Tornatore L;Franzoso G
Transcription factors of the nuclear factor κB (NF-κB) family are central coordinating regulators of the host defence responses to stress, injury and infection. Aberrant NF-κB activation also contributes to the pathogenesis of some of the most common current threats to global human health, including chronic inflammatory diseases, autoimmune disorders, diabetes, vascular diseases and the majority of cancers. Accordingly, the NF-κB pathway is widely considered an attractive therapeutic target in a broad range of malignant and non-malignant diseases. Yet, despite the aggressive efforts by the pharmaceutical industry to develop a specific NF-κB inhibitor, none has been clinically approved, due to the dose-limiting toxicities associated with the global suppression of NF-κB. In this review, we summarise the main strategies historically adopted to therapeutically target the NF-κB pathway with an emphasis on oncology, and some of the emerging strategies and newer agents being developed to pharmacologically inhibit this pathway.
登录
查看更多内容
影响因子:
16
作者:
Bertrand, Mathieu J. M.;Milutinovic, Snezana;Barker, Philip A.
通讯作者:
Barker, Philip A.
影响因子:
15.9
作者:
Barbie, Thanh U.;Alexe, Gabriela;Gillanders, William E.
通讯作者:
Gillanders, William E.
影响因子:
4.8
作者:
Agou, F;Courtois, G;Véron, M
通讯作者:
Véron, M
影响因子:
5.7
作者:
Benetatos, Christopher A.;Mitsuuchi, Yasuhiro;Chunduru, Srinivas K.
通讯作者:
Chunduru, Srinivas K.
影响因子:
4.4
作者:
Cheng, Jing;Montecalvo, Angela;Kane, Lawrence P.
通讯作者:
Kane, Lawrence P.